PrEP (Pre Exposure Prophylaxis) is a new HIV prevention strategy that involves HIV-negative people taking antiretroviral drugs (ARVs) to reduce the risk of becoming infected with HIV if sexually exposed to the virus.
Research is showing that PrEP is highly effective in preventing the sexual transmission of HIV as long as the medication is taken regularly and as directed. The PROUD study in the UK reported that PrEP reduced the risk of HIV infection by 86% for men who have sex with men (MSM). Read more about this study at www.proud.mrc.ac.uk.
Currently (July 2017), PrEP is not available in Ireland, but access is expanding globally.
Read more about PrEP here.